Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Liposarcoma, Myxoid × ribociclib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 34 Neoplasm Metastasis 4 Neoplasms 2 Melanoma 2 Glioblastoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Meningioma 1 Lung Neoplasms 1 Locoregional Recurrence 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer Not Immediately Operated 1 Glioma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Digestive System Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1

Interventions

fludarabine 2 Cyclophosphamide 2 selinexor 1 pazopanib 1 palbociclib 1 mirdametinib 1 fludarabine phosphate 1 Trabectedin 1 Proton Therapy 1 Pioglitazone 1 Ifosfamide 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡